A CRISPR Cas9-based gene drive platform for genetic interaction analysis in Candida albicans

Candida albicans is the leading cause of fungal infections; yet, complex genetic interaction analysis remains cumbersome in this diploid pathogen. Here, we developed a CRISPR–Cas9-based ‘gene drive array’ platform to facilitate efficient genetic analysis in C. albicans. In our system, a modified DNA donor molecule acts as a selfish genetic element, replaces the targeted site and propagates to replace additional wild-type loci. Using mating-competent C. albicans haploids, each carrying a different gene drive disabling a gene of interest, we are able to create diploid strains that are homozygous double-deletion mutants. We generate double-gene deletion libraries to demonstrate this technology, targeting antifungal efflux and biofilm adhesion factors. We screen these libraries to identify virulence regulators and determine how genetic networks shift under diverse conditions. This platform transforms our ability to perform genetic interaction analysis in C. albicans and is readily extended to other fungal pathogens.A CRISPR–Cas9-based gene drive array platform is developed and combined with mating-competent Candida albicans haploids to generate homozygous double-deletion mutants, transforming our ability to do genetic interaction analyses in fungi.

[1]  A. Goffeau,et al.  Efflux-Mediated Antifungal Drug Resistance , 2009, Clinical Microbiology Reviews.

[2]  K. Kashiwagi,et al.  Identification of a Gene for a Polyamine Transport Protein in Yeast* , 1999, The Journal of Biological Chemistry.

[3]  J. Lopez-Ribot,et al.  Our Current Understanding of Fungal Biofilms , 2009, Critical reviews in microbiology.

[4]  Anne-Claude Gingras,et al.  Global Gene Deletion Analysis Exploring Yeast Filamentous Growth , 2012, Science.

[5]  Gary D Bader,et al.  The Genetic Landscape of a Cell , 2010, Science.

[6]  L. Cowen,et al.  Regulatory Circuitry Governing Fungal Development, Drug Resistance, and Disease , 2011, Microbiology and Molecular Reviews.

[7]  Hollis G. Potter,et al.  Author Manuscript , 2013 .

[8]  A. Mitchell,et al.  Candida albicans Gene Deletion with a Transient CRISPR-Cas9 System , 2016, mSphere.

[9]  A. Zaas,et al.  The Hsp90 Co-Chaperone Sgt1 Governs Candida albicans Morphogenesis and Drug Resistance , 2012, PloS one.

[10]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[11]  U. Tatu,et al.  Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris , 2015, BMC Genomics.

[12]  Tami D. Lieberman,et al.  Inexpensive Multiplexed Library Preparation for Megabase-Sized Genomes , 2015, bioRxiv.

[13]  C. Myers,et al.  Genetic interaction networks: toward an understanding of heritability. , 2013, Annual review of genomics and human genetics.

[14]  Owen W. Ryan,et al.  Regulatory circuitry governing morphogenesis in Saccharomyces cerevisiae and Candida albicans , 2012, Cell cycle.

[15]  James E. DiCarlo,et al.  Safeguarding CRISPR-Cas9 gene drives in yeast , 2015, Nature Biotechnology.

[16]  Aaron D. Hernday,et al.  An Efficient, Rapid, and Recyclable System for CRISPR-Mediated Genome Editing in Candida albicans , 2017, mSphere.

[17]  Robert P. St.Onge,et al.  Defining genetic interaction , 2008, Proceedings of the National Academy of Sciences.

[18]  Alexander D. Johnson,et al.  Candida albicans Biofilms and Human Disease. , 2015, Annual review of microbiology.

[19]  Gary D Bader,et al.  Global Mapping of the Yeast Genetic Interaction Network , 2004, Science.

[20]  F. Jossinet,et al.  Genome engineering in the yeast pathogen Candida glabrata using the CRISPR-Cas9 system , 2016, Scientific Reports.

[21]  Gerald R. Fink,et al.  A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families , 2015, Science Advances.

[22]  Christian Schrøder Kaas,et al.  Sequencing the CHO DXB11 genome reveals regional variations in genomic stability and haploidy , 2015, BMC Genomics.

[23]  Christian A. Ross,et al.  A role for the bacterial GATC methylome in antibiotic stress survival , 2016, Nature Genetics.

[24]  Ronald W. Davis,et al.  Systematic pathway analysis using high-resolution fitness profiling of combinatorial gene deletions , 2007, Nature Genetics.

[25]  A. Mitchell,et al.  Complementary Adhesin Function in C. albicans Biofilm Formation , 2008, Current Biology.

[26]  D. Hirata,et al.  The Multidrug Resistance-associated Protein (MRP) Subfamily (Yrs1/Yor1) of Saccharomyces cerevisiae Is Important for the Tolerance to a Broad Range of Organic Anions* , 1996, The Journal of Biological Chemistry.

[27]  Richard J. Bennett,et al.  The ‘obligate diploid’ Candida albicans forms mating-competent haploids , 2013, Nature.

[28]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[29]  A. Sellam,et al.  Pho85, Pcl1, and Hms1 Signaling Governs Candida albicans Morphogenesis Induced by High Temperature or Hsp90 Compromise , 2012, Current Biology.

[30]  D. Reich,et al.  Cost-effective, high-throughput DNA sequencing libraries for multiplexed target capture , 2012, Genome research.

[31]  Kevin P. Byrne,et al.  The Yeast Gene Order Browser: combining curated homology and syntenic context reveals gene fate in polyploid species. , 2005, Genome research.

[32]  L. Cowen,et al.  Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms , 2011, PLoS pathogens.

[33]  Brendan R. Jackson,et al.  Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug‐Resistant Fungus—United States, May 2013–August 2016 , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  B. Wickes,et al.  Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicansBiofilms , 2001, Antimicrobial Agents and Chemotherapy.

[35]  L. J. Douglas,et al.  Biofilm formation by Candida species on the surface of catheter materials in vitro , 1994, Infection and immunity.

[36]  S. Filler,et al.  Candida albicans Als3, a Multifunctional Adhesin and Invasin , 2010, Eukaryotic Cell.

[37]  Alexander D. Johnson,et al.  White-Opaque Switching in Candida albicans Is Controlled by Mating-Type Locus Homeodomain Proteins and Allows Efficient Mating , 2002, Cell.

[38]  E L Lawrence,et al.  Materials for urinary catheters: a review of their history and development in the UK. , 2005, Medical engineering & physics.

[39]  H. Bussey,et al.  Exploring genetic interactions and networks with yeast , 2007, Nature Reviews Genetics.

[40]  P. Sundstrom,et al.  Adhesins in Candida albicans. , 1999, Current opinion in microbiology.

[41]  Junqing Shen,et al.  CaNAT1, a Heterologous Dominant Selectable Marker for Transformation of Candida albicans and Other Pathogenic Candida Species , 2005, Infection and Immunity.

[42]  J. Morschhäuser.  The genetic basis of fluconazole resistance development in Candida albicans. , 2002, Biochimica et biophysica acta.

[43]  J. C. Rhodes,et al.  Protein kinase A and fungal virulence , 2012, Virulence.

[44]  J. Dunlap,et al.  Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus , 2015, Eukaryotic Cell.